Gut microbes and metabolic disorders- dissection of the underlying preventive and causal mechanisms and development of personalized dietary treatment strategies
Description of the granted funding
Metabolic disorders (MDs) including non-alcoholic fatty liver disease (NAFLD) are major health problems. We will use commensal gut microbes to elucidate the mechanisms that affect host metabolic health both at organism and molecular level. This knowledge is needed to further understand the role of specific diets and therapeutic use of bacteria for prevention/treatment of MDs. Specifically, we will confirm the disease-causing/preventive role of the specific gut microbes, elucidate the underlying pathologic mechanisms for the development of effective treatment strategies, combine data collected from human diets, gut microbiota composition, and in vitro studies to identify specific dietary compounds that affect the abundance of the harmful and beneficial microbes, to treat/prevent MDs in animal models and humans targeting the abundance harmful and beneficial microbes by specific diets.
Show moreStarting year
2017
End year
2022
Granted funding
Related funding decisions
335802
Research costs of Academy Research Fellows(2020)
199 847 €
314212
Research costs of Academy Research Fellows(2017)
328 629 €
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Other information
Funding decision number
308042
Fields of science
Plant biology, microbiology, virology
Research fields
Mikrobiologia
Identified topics
diabetes, medicine, metabolic diseases